|
| ORIGINAL ARTICLE |
 |
|
|
| Year : 2020 |
Volume
: 31 | Issue : 5 | Page
: 1014-1024 |
|
The Comparison Spondin 2 Levels in Primary Glomerular Diseases
Serdar Kahvecioglu1, Alparslan Ersoy2, Yasemin Üstundag3, Yavuz Ayar4, Cuma Bülent Gül1, Abdülmecit Yildiz2, Selin Akturk Esen5, Ibrahim Dogan6, Aysegul Oruc2
1 Department of Nephrology, Health Science University Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey
2 Department of Nephrology, Uludag University Faculty of Medicine, Bursa, Turkey
3 Department of Biochemistry, Health Science University Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey
4 Department of Nephrology, Bursa City Hospital, Bursa, Turkey
5 Department of Internal Medicine, Gürsu Cüneyt Yildiz State Hospital, Bursa, Turkey
6 Department of Nephrology, Hitit University Erol Olçok Training and Research Hospital, Çorum, Turkey
Correspondence Address:
Selin Akturk Esen
Department of Internal Medicine, Gürsu Cüneyt Yildiz State Hospital, Bursa
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-2442.301166
|
|
|
Spondin 2 (SPON2) plays an important role in multiple processes and is a member of the Spondin 2/F-spondin family of extracellular matrix proteins. We investigated serum SPON2 levels and its correlation with renal functions and urine protein excretion in different glomerular diseases. The cohort included 97 consecutive adults with persistant proteinuria (>300 mg/day) with the diagnosis of focal segmental glomerulosclerosis (FSGS), membranous glomerulonephritis (MN), IgA nephropathy (IgAN), membranoproliferative glomerulonephritis (MPGN), and AA amyloidosis and the control groups with 15 polycystic kidney disease (PKD) and 32 healthy people. Serum SPON2 levels in MN (64.6 ng/mL), FSGS (47.8 ng/mL), IgAN (52.6 ng/mL), MPGN (54.6 ng/mL), and AA amyloidosis (60.7 ng/mL) groups were higher than those of the control (26.4 ng/mL) and nonglomerular disease groups (PKD) (15.3 ng/mL). Only serum SPON2 levels were correlated with serum uric acid and triglyceride levels in patients with glomerular disease. This is the first study to show that serum SPON2 levels are similar in different glomerular diseases and that there is no correlation between SPON2 and proteinuria grade.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
|
|
